Akèy › Ensifizyans renn
Etid klinik pou Ensifizyans renn ap rekrite nan Etazini
26 etid pou Ensifizyans renn ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA7 etid
- Houston, TX6 etid
- Orlando, FL5 etid
- Philadelphia, PA4 etid
- Dallas, TX4 etid
- Hialeah, FL4 etid
- Durham, NC4 etid
- Ann Arbor, MI3 etid
- Omaha, NE3 etid
- New Haven, CT3 etid
- Phoenix, AZ3 etid
- St. Louis, MO3 etid
- Raleigh, NC3 etid
- Rochester, MN3 etid
- Queens, NY3 etid
- Nashville, TN3 etid
- Davie, FL3 etid
- Seattle, WA3 etid
- New York City, NY3 etid
- Cedar Rapids, IA3 etid
- Tampa, FL3 etid
Pa eta
- Alabama3 etid
- Arizona3 etid
- Connecticut3 etid
- Florid13 etid
- Georgia5 etid
- Illinois3 etid
- Iowa3 etid
- Kalifòni7 etid
- Kentucky3 etid
- Maryland3 etid
- Massachusetts7 etid
- Michigan4 etid
- Minnesota4 etid
- Missouri4 etid
- Nebraska3 etid
- New Jersey3 etid
- New York6 etid
- North Carolina6 etid
- Ohio3 etid
- Pennsylvania6 etid
- South Carolina3 etid
- Tennessee6 etid
- Texas7 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Delayed Tolerance Through Mixed Chimerism
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT05900401A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05805709Concomitant Renal and Urinary Bladder Allograft Transplantation
Ap rekriteFaz 1 bonè
Laj 1 a 60 · Tout sèks · Mizajou Sep 24, 2026 · NCT04626167A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07734610Product Surveillance Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07741604Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Sep 4, 2026 · NCT07754331Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 6, 2026 · NCT06613568SPYRAL GEMINI Pilot Study
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jun 16, 2026 · NCT07559396CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou May 22, 2026 · NCT06056102A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou May 12, 2026 · NCT07315360Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07446296Empagliflozin Treatment in Kidney Transplant Recipients
Ap rekriteFaz 4
Laj 19 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT06013865Shingrix in Renal Transplant Recipients
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Apr 8, 2026 · NCT04128189Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
Ap rekrite
Laj 22 a 85 · Tout sèks · Mizajou Mar 19, 2026 · NCT07017933Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Ap rekriteFaz 1 bonè
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT06142396Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT06623630SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06001827Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT04240054Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT06752577A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Dec 22, 2025 · NCT04671771Post-Filter Hematocrit
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT07293936Prevent Cardiac Surgery Associated AKI Trial
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Oct 8, 2025 · NCT06620523Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.